Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.30404 EPS, expectations were $-0.04. Operator ...
Operator: Good afternoon, ladies and gentlemen, and welcome to the CytoSorbents Corp. Third Quarter 2025 Earnings Conference ...
PetVivo Holdings, Inc. ( OTCPK:PETV) Q2 2026 Earnings Call November 14, 2025 5:00 PM EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback